Work

Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2025.300333

Authors: Laura Alibert, Sara Ovejero, Julie Devin, Morgane Thomas, Alboukadel Kassambara, Matthieu Angles, Guilhem Requirand, Nicolas Robert, Laure Vincent, Guillaume Cartron, Anne Marie Martinez, Charles Herbaux, Giacomo Cavalli, Jérôme Moreaux, Caroline Bret

Institutions: Centre National de la Recherche Scientifique, Institut de Génétique Humaine, Centre Hospitalier Universitaire de Montpellier, Université de Montpellier, Institut Universitaire de France

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation ARC pour la Recherche sur le Cancer, Fondation de France, Institut Universitaire de France, Institut National Du Cancer, Direction Générale de l’offre de Soins, MSDAVENIR, European Health and Digital Executive Agency

Awards: G1796818391, G3010542489, Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma, G5607072047, G6971814208, G7080048889, Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation during B to plasma cell differentiation

OpenAlex ID: W7154598675

FWCI:

Cites:

Cited by:

Related to: